Edmonton, Alberta–(Newsfile Corp. – December 31, 2021) – Radient Technologies Inc. (TSXV: RTI) (“Radient” or the “Company”), a commercial manufacturer of diverse, novel and high-quality cannabis extracts and packaged products, announces that it has upsized and closed its previously announced non-brokered private placement financing (the “Offering”). For more information about the Offering, please see the Company’s press release dated December 15, 2021, which is available under the Company’s profile on SEDAR at www.sedar.com. Pursuant to the Offering, the Company has issued 20,880,714 units (the “Units”) at a price of $0.06 per Unit for gross proceeds of $1,252,842. Each Unit consists of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to purchase one common share of the Company at $0.10 per share at any time prior to June 30, 2023. The Company intends to use the net proceeds of the Offering for growth initiatives and general corporate purposes. No finder’s fees were paid in connection with the Offering.

Certain insiders of the Company have directly or indirectly purchased an aggregate of 12,014,988 Units pursuant to the Offering for gross proceeds of $720,899. Such participation is considered a “related party transaction” as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company is relying on the exemptions from the valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101, respectively, as the fair market value of the participation in the private placement by insiders does not exceed 25% of the market capitalization of the Company, as determined in accordance with MI 61-101. The Company did not file a material change report at least 21 days prior to the closing of the Offering as details of the participation by insiders were not settled until shortly prior to closing, and the Company wished to close the Offering on an expedited basis.

All securities issued in connection with the Offering are subject to a statutory hold period expiring on May 1, 2022. Completion of the Offering remains subject to receipt of final approval of the TSX Venture Exchange.

Shares for Debt Settlements

The Company is also pleased to announce that it has entered into agreements to settle $281,500 of its outstanding cash indebtedness owed to various third-party creditors by way of the issuance of 4,691,668 common shares of the Company at an effective price per share of $0.06 (the “Debt Settlement”). In accordance with applicable securities laws, the shares issued in connection with the Debt Settlement will be subject to a four month and one day hold period and the approval of the TSX Venture Exchange.

About Radient

Radient is a commercial manufacturer of diverse, novel and high-quality cannabis extracts and packaged products. Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Radient is focused on innovation with expertise in formulations and technologies offering unique solutions in the cannabis and wellness space. RadientInc.com

Contact Information:
Harry Kaura, CEO & Director
[email protected]
Ph: 780 465 1318

Forward Looking Information:

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the Debt Settlement and the issuance of common shares in connection therewith and the Offering, including the Company’s intended use of net proceeds. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those expressed or implied by such forward-looking information, including but not limited to: general business, economic, competitive, geopolitical and social uncertainties; risks associated with operation in the cannabis sector; and other risks inherent in the cannabis industry. Although Radient has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

By Rebecca Victoria Olmos | TheCannifornian.com Correspondent

I know of a cannabis customer that walks into the dispensary, doesn’t look at the menu, and tells the budtender, “Give me two really good 8ths.” He takes whatever the budtender provides and never complains.

That is certainly one way to do it. But for those that what to become a little more involved with the process, here are a few things to consider when choosing your next strain. 

Knowing how much you’d like to spend can save you trouble at the end of the transaction. Be prepared that taxes in the state of California can be anywhere up to 38%.

I only mention this because it will be your first step in narrowing down your choices. You can find excellent quality buds within any budget. And don’t worry, price doesn’t always equate to the quality of the flower or the effects you’ll get.

Indica, sativa, or hybrid are the classic categories of flowers. Sativa is known for its more uplifting effects, indica for its sedating feelings, and hybrids fall anywhere in between those two. THC percentages have also traditionally been the defining factor in users knowing how potent a strain will be.

However, a strain’s terpene profile and cannabinoid content tends to better gauge how it will affect an individual. Flower high in limonene can provide energizing feelings, and myrcene dominate strains may feel more relaxing.

They say “the nose knows,” meaning if you like the smell, you’ll most likely enjoy the effects. But, in the recreational cannabis market, all buds are prepackaged. In the covid era, even if a dispensary offers sample jars, you can’t smell the flower most of the time. Refer back to previous information about terpenes. Budtenders should be also able to help you find this information.

What values are important to you? Women-owned? Equity brand? Environmentally friendly? Community outreach? Cannabis companies stand for much more than just weed these days. Spend your dollar wisely.

If you’re new on your strain journey, keep a journal with strain names, brands, terpenes, cannabinoids and how they made you feel. If you can tell a budtender what you didn’t like, they can help steer you towards a strain you might enjoy better.

And if all of it still overwhelms you, ask your budtender what they’re smoking or what other customers have been enjoying. An open mind and curiosity are essential to finding a perfect strain for you.